Momentum Awards, which support the UK Dementia Research Institute (DRI). Today’s announcement involves six universities being awarded £4.3 million from the MRC to help develop UK-based dementia research. Judging from the press release, there appears to be a serious focus on recruiting and/or retaining the services of high-flying researchers.
- University of Bristol: regarding the Sensor Platform for Healthcare in a Residential Environment (SPHERE).
- Cardiff University: exploring immune pathways relevant to dementia and development of stem cell (iPSC) models of neurodegenerative disease.
- University of Edinburgh: exploring neuroinflammation research.
- Kings College London: regarding a new Neuroinflammation Research Cluster within the new Maurice Wohl Clinical Neuroscience Institute.
- University of Manchester: regarding a cluster of pump-priming “high risk-high payoff” projects across a range of dementia topics (such as proteostasis dysfunction, neuroinflammation, neurovascular dysfunction and cognitive-clinical neurosciences, biomarkers and diagnosis).
- University of Oxford: exploring other “high risk-high payoff” projects too abstruse to contemplate.
MRC awards £4.3m to boost UK research base in dementia. London: Medical Research Council (MRC), October 25th 2016.
An earlier piece on the Momentum Awards and the award application process, undiscovered previously:
Momentum Awards: Institutional pump-priming awards for dementia research. London: Medical Research Council (MRC), May 16th 2016.
The MRC Centre for Neurodevelopmental Disorders at King’s College London
The MRC has awarded £3 million to King’s College London for the MRC Centre for Neurodevelopmental Disorders.
New world-class centre to reveal biological clues behind brain disorders. London: Medical Research Council (MRC), November 9th 2016.